(Q43253844)

17 November 2017

title

Sorafenib-induced hepatic encephalopathy (English)

1 reference

17 November 2017

Anne-Bérengère Marks

1

1 reference

17 November 2017

Romain Gerard

2

1 reference

17 November 2017

Peggy Fournier

3

1 reference

17 November 2017

Patrick Coupe

4

1 reference

17 November 2017

Sophie Gautier

5

1 reference

17 November 2017

language of work or name

English

0 references

publication date

27 October 2009

1 reference

Annals of Pharmacotherapy

17 November 2017

published in

1 reference

17 November 2017

volume

43

1 reference

17 November 2017

issue

12

1 reference

17 November 2017

page(s)

2121

1 reference

Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: results from a phase I extension trial.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M457

Crossref

reference URL

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M457

Crossref

reference URL

21 January 2018

Identifiers

DOI

10.1345/APH.1M457

1 reference

17 November 2017

1 reference